Style de citation APA

Trondl, R., Heffeter, P., Jakupec, M. A., Berger, W., & Keppler, B. K. (2012). NKP-1339, a first-in-class anticancer drug showing mild side effects and activity in patients suffering from advanced refractory cancer. BioMed Central.

Style de citation Chicago

Trondl, Robert, Petra Heffeter, Michael A. Jakupec, Walter Berger, et Bernhard K. Keppler. NKP-1339, a First-in-class Anticancer Drug Showing Mild Side Effects and Activity in Patients Suffering From Advanced Refractory Cancer. BioMed Central, 2012.

Style de citation MLA

Trondl, Robert, et al. NKP-1339, a First-in-class Anticancer Drug Showing Mild Side Effects and Activity in Patients Suffering From Advanced Refractory Cancer. BioMed Central, 2012.

Attention : ces citations peuvent ne pas être correctes à 100%.